Ningbo PIA Automation (SH:688306) Guo Ji Jin Rong Bao·2025-10-20 11:31Core Viewpoint - Ningbo Junpu Intelligent Manufacturing Co., Ltd. is making a significant strategic investment in the intelligent robotics sector, aiming to raise up to 1.161 billion yuan through a private placement to enhance its research and industrialization projects in this field [1][4]. Group 1: Company Overview - Established on January 10, 2017, Junpu Intelligent focuses on intelligent manufacturing equipment and digital software services, providing customized assembly and inspection solutions for global manufacturers in the automotive, consumer goods, and healthcare sectors [3]. - The company has experienced rapid revenue growth, with projected revenues of 1.995 billion yuan, 2.096 billion yuan, and 2.662 billion yuan for the years 2022 to 2024, respectively [3]. Group 2: Fundraising and Investment Plans - The private placement aims to raise a maximum of 1.161 billion yuan, which will be allocated to four main areas: intelligent robotics R&D and industrialization, global capability enhancement for medical health intelligent devices, information technology construction, and working capital supplementation [3]. - The intelligent robotics R&D and industrialization project will receive an investment of 623 million yuan, with 550 million yuan coming from the raised funds, and is expected to take 36 months to complete [3]. Group 3: Strategic Focus and Market Position - Junpu Intelligent is strategically betting on the embodied intelligent robotics industry, which is recognized as a key area in the smart manufacturing sector, with humanoid robots being a national strategic priority [4]. - The company has established a comprehensive technical capability in embodied intelligent robotics and has launched two generations of humanoid robot products, collaborating with other firms in the industry [4]. Group 4: Current Financial Status and Previous Fund Usage - As of September 30, 2025, the company still has 89.055 million yuan from its IPO fundraising that has not been utilized, primarily due to project delays and unclear plans for excess funds [4]. - The investment progress for the production base project is at 99.96%, with a delay until March 2026, while the medical robot R&D project is only 42.86% complete, with a delay until September 2026 [5].